Fibrate therapy may lower the risks of mortality and progression to end-stage kidney disease (ESKD), despite raising the risk for new onset stage 3 or higher chronic kidney disease (CKD), a new study ...

Immune checkpoint inhibitor-based combinations have become the preferred first-line therapy for patients with metastatic clear cell renal cell carcinoma, but more than a third of eligible patients do ...

Just a couple of months ago, a 24-year-old from Scottsdale with chronic kidney disease said he thought he found a donor, but ...

People with diseases caused by rare mutations have fewer options and poorer prospects than other patients despite rapid ...

NBA Hall of Famer Alonzo Mourning beat kidney failure and prostate cancer thanks to early detection — and now he’s using his ...